EVALUATION OF THE PAIN MANAGEMENT EFFICIENCY AFTER PRIMARY HIP ARTHROPLASTY: RESULTS OF KVEST PROJECT

Cover Page


Cite item

Abstract

Introduction. Celecoxibum being one of high-selective COX-2 inhibitors is specifically inhibiting COX-2 in vivo not influencing protective effect of COX-1. Celecoxibum systemic administration after primary arthroplasty in combination with local infiltration anesthesia has a number of advantages. Purpose of the study. To evaluate the efficiency of postoperative pain relief by Celecoxibum in primary hip arthroplasty using standard and minimally invasive approaches as well as to analyze the pain syndrome dynamics by a method of local infiltration anesthesia (LIA).

Material and methods. The study included 91 patients with hip arthritis of grade III-IV without severe anatomical alterations who underwent primary hip arthroplasty in the Vreden Research institute of traumatology and orthopaedics during 2017. Patients were randomized by type of surgical approach used (standard or minimally invasive), the authors compared monotherapy by Celecoxibum with a multimodal anesthesia which included systemic Celecoxibum administration in combination with LIA. Additional evaluation of two LIA methods was conducted in the group of patients with standard approach.

Results. Pain syndrome dynamics was comparable in all groups — minimal intensity within first day after the surgery and almost complete absence of pain on day 7. However, on day 3 variance between the subgroups increased: the best outcome was observed in the group of minimally invasive approach combined with LIA VAS score was 1.0 (95% CI, 0–1); in the group with standard approach without LIA VAS score was 4.5 (95% CI, 2–7); in the group with standard approach with a single LIA VAS score was 2.6 (95%CI, 0–5); in the group with standard approach with threestage LIA VAS score was 2.4 (95%CI, 0–5); in the group with minimally invasive approach without LIA VAS score was 3,9 (95% CI, 0–2). On day 7 the parameters in all groups demonstrated no statistically significant variances with a minor elevation in cases when LIA was not performed and with average VAS score of 0.8 (95% CI, 0–4). By day 14 pain syndrome was absent or within a range of 1 point in all patients, by this treatment stage Celecoxibum medication was stopped in 37 out of 91 patients (40.7%).

Conclusion. Administration of Celecoxibum per os (200 mg twice per 24 hours) in combination with LIA by Ropivacaine and dexamethasone solution in primary hip arthroplasty provides fast relief of pain facilitating early mobilization of patients and accelerated rehabilitation. Celecoxibum safety in therapeutic dose was also proven.

About the authors

I. I. Shubnyakov

Vreden Russian Research Institute of Traumatology and Orthopedics

Author for correspondence.
Email: shubnyakov@mail.ru

Dr. Sci. (Med.), Chief Researcher

8, ul. Akad. Baykova, 195427, St. Petersburg

Russian Federation

A. A. Nesinov

Vreden Russian Research Institute of Traumatology and Orthopedics

Email: fake@neicon.ru

Postgraduate Student

8, ul. Akad. Baykova, 195427, St. Petersburg

Russian Federation

M. Yu. Goncharov

Vreden Russian Research Institute of Traumatology and Orthopedics

Email: fake@neicon.ru

Cand. Sci. (Med.), Head of the department N 5

8, ul. Akad. Baykova, 195427, St. Petersburg

Russian Federation

D. G. Pliev

Vreden Russian Research Institute of Traumatology and Orthopedics

Email: fake@neicon.ru

Cand. Sci. (Med.) Head of Hip Pathology Department

8, ul. Akad. Baykova, 195427, St. Petersburg

Russian Federation

References

  1. Шубняков И.И., Тихилов Р.М., Николаев Н.С., Григоричева Л.Г., Овсянкин А.В., Черный А.Ж., Дроздова П.В., Денисов А.О., Вебер Е.В., Кузьмина И.В. Эпидемиология первичного эндопротезирования тазобедренного сустава на основании данных регистра артропластики РНИИТО им. Р.Р. Вредена. Травматология и ортопедия России. 2017;23(2):81-101. doi: 10.21823/2311-2905-2017-23-2-81-101. Shubnyakov I.I., Tikhilov R.M., Nikolayev N.S., Grigoricheva L.G., Ovsyankin A.V., Chernyy A.Zh., Drozdova P.V., Denisov A.O., Veber E.V., Kuzmina I.V. [Epidemiology of Primary Hip Arthroplasty: Report from Register of Vreden Russian Research Institute of Traumatology and Orthopedics]. Travmatologiya i ortopediya Rossii [Traumatology and orthopedics of Russia]. 2017;23(2):81-101. (in Russian). doi: 10.21823/2311-2905-2017-23-2-81-101.
  2. Агеенко А.М., Садовой М.А., Шелякина О.В., Овтин М.А. Технология ускоренной реабилитации после эндопротезирования тазобедренного и коленного суставов (обзор литературы). Травматология и ортопедия России. 2017;23(4):146-155. doi: 10.21823/2311-2905-2017-23-4-146-155. Ageyenko A.M., Sadovoy M.A. Shelyakina O.V. Ovtin M.A. [Fast-track Hip and Knee Arthroplasty (Literature Review)]. Travmatologiya i ortopediya Rossii [Traumatology and orthopedics of Russia]. 2017;23(4):146-155. (in Russian). doi: 10.21823/2311-2905-2017-23-4-146-155.
  3. Eid T., Bucknall T. Documenting and implementing evidence-based post-operative pain management in older patients with hip fractures. J Orthop Nurs. 2008;12:90-98. doi: 10.1016/j.joon.2008.07.003.
  4. Illgen R.L., Pellino T.A., Gordon D.B., Butts S., Heiner J.P. Prospective analysis of a novel long-acting oral opioid analgesic regimen for pain control after total hip and knee arthroplasty. J Arthroplasty. 2006;21:814-820. doi: 10.1016/j.arth.2005.10.011.
  5. Каратеев А.Е., Насонов Е.Л., Яхно Н.Н., Ивашкин В.Т., Чичасова Н.В., Алексеева Л.И. и др. Клинические рекомендации «Рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике». Современная ревматология. 2015;(1):4-23. Karateyev A.E., Nasonov E.L., Yakhno N.N., Ivashkin V.T., Chichasova N.V., Alekseyeva L.I. et al. [Clinical guidelines «Rational use of nonsteroidal antiinflammatory drugs (NSAIDs) in clinical practice»]. Sovremennaya revmatologiya [Modern Rheumatology Journal]. 2015;(1):4-23. (in Russian).
  6. Moore N.D. In search of an ideal analgesic for common acute pain. Acute Pain. 2009;11:129-137. doi: 10.1016/j.acpain.2009.09.003.
  7. Каратеев А.Е., Лила А.М., Чурюканов М.В. Скоробогатых К.В., Амелин А.В., Захаров Д.В. и др. Оценка эффективности алгоритма назначения нестероидных противовоспалительных препаратов (НПВП), основанного на анализе факторов риска лекарственных осложнений, в реальной клинической практике. Результаты всероссийского проекта «ПРИНЦИП» (Применение Рекомендаций по Использованию НПВП: Целенаправленное Изменение Практики). Научно-практическая ревматология. 2017;55(5):485-492. doi: 10.14412/1995-4484-2017-485-492. Karateev A.E., Lila A.M., Churyukanov M.V., Skorobogatykh K.V., Amelin A.V., Zakharov D.V. et al. [Evaluation of the effectiveness of a nonsteroidal antiinflammatory drug (NSAID) selection algorithm based on the analysis of risk factors for drug-induced complications in real clinical practice: The results of the All-Russian PRINCIPLE project (Application of recommendations for NSAID use: a Goal-Oriented Change of Practice)]. Nauchno-prakticheskaya revmatologiya [Rheumatology Science and Practice]. 2017;55(5):485-492. (in Russian). doi: 10.14412/1995-4484-2017-485-492.
  8. Sostres C., Gargallo C.J., Arroyo M.T., Lanas A. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2010;24:121-132. doi: 10.1016/j.bpg.2009.11.005.
  9. Harirforoosh S., Asghar W., Jamali F. Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications. J Pharm Pharm Sci. 2013;16(5):821-847.
  10. Moore A., Makinson G., Li C. Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: meta-analysis of 51,000 patients enrolled in 52 randomized trials. Arthritis Res Ther. 2013;15(1):R6. doi: 10.1186/ar4134.
  11. Trelle S., Reichenbach S., Wandel S., Hildebrand P., Tschannen B., Villiger P.M. et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network metaanalysis. BMJ. 2011;342:c7086. doi: 10.1136/bmj.c7086.
  12. Varas-Lorenzo С., Riera-Guardia N., Calingaert B., Castellsague J., Salvo F., Nicotra F., et al. Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies. Pharmacoepidemiol Drug Saf. 2013;22(6):559-570. doi: 10.1002/pds.3437.
  13. Chou R., Gordon D.B., de Leon-Casasola O.A., Rosenberg J.M., Bickler S., Brennan T. et al. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016;17(2):131-157. doi: 10.1016/j.jpain.2015.12.008.
  14. Raeder J.C. Local infiltration analgesia for pain after total knee replacement surgery: a winner or just a strong runner-up? Anesth Analg. 2011;113(4):684-686. doi: 10.1213/ANE.0b013e3182288e14.
  15. Ghomrawi H.M.K., Mancuso C.A., Dunning A., Gonzalez Della Valle A., Alexiades M., Cornell C. et al. Do Surgeon Expectations Predict Clinically Important Improvements in WOMAC Scores After THA and TKA? Clin Orthop Relat Res. 2017;475(9):2150-2158. doi: 10.1007/s11999-017-5331-8.
  16. Harding P., Holland A.E., Delany C., Hinman R.S. Do activity levels increase after total hip and knee arthroplasty? Clin Orthop Relat Res. 2014;472(5):1502- 1511. doi: 10.1007/s11999-013-3427-3.
  17. Højer Karlsen A.P., Geisler A., Petersen P.L., Mathiesen O., Dahl J.B. Postoperative pain treatment after total hip arthroplasty: a systematic review. Pain. 2015;156(1):8-30. doi: 10.1016/j.pain.0000000000000003.
  18. Affas F. Local infiltration analgesia in knee and hip arthroplasty efficacy and safety. Scand J Pain. 2016;13: 59-66. doi: 10.1016/j.sjpain.2016.05.041.
  19. Fusco P., Cofini V., Petrucci E., Scimia P., Fiorenzi M., Paladini G. et al. The addition of continuous wound infusion of local anaesthetics to local infiltration in the management of postoperative pain and rehabilitation after total hip arthroplasty: a double-blind randomized controlled trial. Minerva Anestesiol. 2017. doi: 10.23736/S0375-9393.17.12110-3.
  20. Andersen L.Ø., Kehlet H. Analgesic efficacy of local infiltration analgesia in hip and knee arthroplasty: a systematic review. Br J Anaesth. 2014;113(3):360-374. doi: 10.1093/bja/aeu155.
  21. Titman S., Hommel A., Dobrydnjov I., Johansson A. The efficacy of high volume of local infiltration analgesia for postoperative pain relief after total hip arthroplasty under general anaesthesia – A randomised controlled trial. Int J Orthop Trauma Nurs. 2018;28:16-21. doi: 10.1016/j.ijotn.2017.10.003.
  22. Russo M.W., Parks N.L., Hamilton W.G. Perioperative pain management and anesthesia: a critical component to rapid recovery total joint arthroplasty. Orthop Clin North Am. 2017;48(4):401-405. doi: 10.1016/j.ocl.2017.06.006.

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 82474 от 10.12.2021.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies